ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 923

Redox Dependent Conformational Changes Of The Autoantigen La Are Responsible For Its Shuttling, Translocation and a Pathophysiological Role Of Anti-La Autoantibodies

Irene Michalk1, Nicole Berndt1, Claudia C. Bippes1, Holger Bartsch2, Stefanie Koristka3, Claudia Arndt1, Anja Feldmann1, Biji T. Kurien4, Robert Hal Scofield5, A. Darise Farris6, Judith A. James7, Marc Cartellieri1 and Michael Bachmann1, 1Inst. Immunology, Carl Gustav Carus TU-Dresden, Dresden, Germany, 2Inst. Immunol., Carl Gustav Carus TU-Dresden, Dresden, Germany, 3Carl Gustav Carus TU-Dresden, Dresden, Germany, 4College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 5Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation; Department of Medicine, University of Oklahoma Health Sciences Center; US Department of Veterans Affairs Medical Center, Oklahoma City, OK, 6Arthritis & Immunology Program, Oklahoma Medical Research Foun, Oklahoma City, OK, 7Oklahoma Medical Research Foundation, Oklahoma City, OK

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: autoantibodies, autoantigens and autoimmunity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cells in Human and Animal Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Since their detection a pathophysiological role of antibodies (abs) to extractable nuclear autoantigens including anti-La abs has been controversially discussed. Stainings of anti-La abs point to an exclusive nuclear localization. However, we and others have also seen an intracellular shuttling and an occurrence on the cell surface. All conditions leading to a translocation of La onto the cell surface were later found to induce apoptosis. Therefore, a pathophysiological contribution of anti-La abs appears rather unlikely. And, even until today, the mechanisms underlying the shuttling and translocation of the autoantigen are still largely unclear.

Methods:

Ten novel monoclonal abs (mabs) were established, characterized by epitope mapping and used for analysis of intra- and cell surface localization of La by immunoblotting, ELISA, epifluorescence microscopy and FACS. The observed redox dependent localization was confirmed by analysis of native and cystein mutant (GFP) La forms. In addition to mabs, human anti-La abs directed to redox dependent forms of La were isolated from autoimmune sera, tested for binding to cell surface La and induction of an ADCC using Chromium-release and FACS-based cytotoxicity assays.   

Results:

Reactivities of novel anti-La mabs were found to depend on reducing/non-reducing conditions when analyzed by immunoblotting or ELISA. The sensitivity to oxidation was lost when all three cystein residues present in La were mutated. Oxidation of native La protein or cystein mutants in which only one or two cystein residues were mutated leads to inter- and intra cystein disulfide bonds, and thereby to the formation of dimers and higher oligomers in vitro and in vivo. Oxidative stress results in  oxidation of La and causes a separation from a redox dependent nuclear retention partner. Thereafter, La translocates to the cytoplasm and its reentry into the nucleus is blocked resulting in a cytoplasmic enrichment. Oxidation of La can occur in a cell type specific manner. E.g. LPS treatment causes a translocation only in cells expressing TLR4. Dying cells can release La. Released La binds strongly to the surface of neighbouring intact cells. The binding depends on the cell type and the oxidative status of the protein. Only oxidized La binds strongly to the surface of cells including to epithelial, endothelial, blood DCs and other APCs but not to NK- or T cells. Surface bound La is available for binding of anti-La abs, thereby mediating ADCC. Furthermore, it can bind nucleic acids including DNA which improves the binding of other autoantibodies such as anti-DNA abs. Such La/nucleic acid complexes can lead to maturation of DCs.

Conclusion:

Under physiological conditions the shuttling of La is favoured to a nuclear localization. Redox dependent conformational changes of La alter this balance resulting in an enrichment of La in the cytoplasm. Dead cells release La which then binds to the surface of intact living cells in a redox dependent manner. Anti-La abs can bind to surface La and cause an ADCC. These redox dependent alterations explain why anti-La abs can become of pathophysiological relevance only under conditions causing acute phases of disease in autoimmune patients.


Disclosure:

I. Michalk,
None;

N. Berndt,
None;

C. C. Bippes,
None;

H. Bartsch,
None;

S. Koristka,
None;

C. Arndt,
None;

A. Feldmann,
None;

B. T. Kurien,
None;

R. H. Scofield,

research grants from NIH and Department of Veterans Affairs,

2,

Employed by the University of Oklahoma and Department of Veterans Affair,

3;

A. D. Farris,
None;

J. A. James,

Pfizer Inc,

2,

GSK,

5;

M. Cartellieri,
None;

M. Bachmann,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/redox-dependent-conformational-changes-of-the-autoantigen-la-are-responsible-for-its-shuttling-translocation-and-a-pathophysiological-role-of-anti-la-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology